Company Filing History:
Years Active: 2017-2019
Title: Ekkehard Lang: Innovator in Stem Cell Therapy
Introduction
Ekkehard Lang is a notable inventor based in Weinbach, Germany. He has made significant contributions to the field of cell therapy, particularly in stem cell transplantation. With a focus on improving the efficacy of stem cell therapies, Lang has been awarded 2 patents for his innovative methods.
Latest Patents
Lang's latest patents include a method for reducing the inflammatory activity of a stem cell transplant. This method is crucial in the field of cell therapy, as it aims to enhance the effectiveness of stem cell transplantation therapy. The patent outlines a process for preparing a stem cell transplant with reduced inflammatory activity by suspending a composition of stem cells in fibrinogen-depleted plasma and/or in fibrinogen and C-reactive protein-depleted plasma. This innovative approach is expected to improve patient outcomes in stem cell therapies.
Career Highlights
Ekkehard Lang is associated with Neuroplast Beheer B.V., where he continues to develop and refine his groundbreaking techniques in stem cell therapy. His work is characterized by a commitment to advancing medical science and improving therapeutic strategies for patients.
Collaborations
Lang has collaborated with notable colleagues in his field, including Johannes Petrus Jozef Maria De Munter and Erik Charles Marie Joseph Wolters. These collaborations have further enriched his research and development efforts.
Conclusion
Ekkehard Lang's contributions to stem cell therapy exemplify the impact of innovative thinking in medicine. His patents and ongoing work at Neuroplast Beheer B.V. highlight the importance of reducing inflammatory activity in stem cell transplants, paving the way for more effective treatments.